The chemical class termed Spata31d1c Inhibitors encompasses compounds that can indirectly modulate the function or expression of the protein SPATA31D1C. These inhibitors work by targeting various biochemical pathways and cellular processes that are crucial for the proper functioning of SPATA31D1C, often involved in spermatogenesis and cell cycle regulation. For instance, compounds like Withaferin A and LY294002 can disrupt the Akt signaling pathway, which is implicated in numerous cellular processes, including those that may engage SPATA31D1C. Cell cycle inhibitors such as Palbociclib can arrest the cell cycle, thereby affecting the cellular context in which SPATA31D1C operates.
Gene expression modulators like Trichostatin A and 5-Azacytidine can alter chromatin structure and DNA methylation patterns, respectively, potentially leading to changes in SPATA31D1C expression levels. Inhibitors of signaling pathways, such as PD98059, U0126, and SP600125, can alter MAPK/ERK and JNK signaling, which are crucial for various cellular responses and may be related to the biological functions of SPATA31D1C. Compounds like Y-27632 that affect cytoskeleton dynamics can influence cell division and morphology, processes that SPATA31D1C could be involved in. Lastly, XAV-939's impact on the Wnt/β-catenin pathway demonstrates how altering signal transduction can influence the activity and function of proteins like SPATA31D1C within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Inhibits the Akt signaling pathway; can disrupt cell survival signals that may be necessary for SPATA31D1C function. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor; can arrest cell cycle, potentially affecting SPATA31D1C-related cell cycle processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor; can alter chromatin structure and gene expression, possibly affecting SPATA31D1C expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor; can change gene expression patterns, potentially impacting SPATA31D1C expression. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $106.00 | 8 | |
Sphingolipid synthesis inhibitor; can affect membrane composition and signal transduction, influencing SPATA31D1C function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor; can affect cell growth and proliferation, potentially influencing SPATA31D1C activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor; can alter MAPK signaling, potentially affecting processes that SPATA31D1C is involved in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK1/2 inhibitor; can disrupt MAPK/ERK signaling, potentially affecting SPATA31D1C-related functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; can alter stress response signaling, potentially impacting SPATA31D1C activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor; can affect cytoskeleton dynamics, potentially influencing SPATA31D1C's role in cell division. | ||||||